Takeshima TL - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.

Zhang X, Bustos MA, Gross R, Ramos RI, Takeshima TL, Mills GB, Yu Q, Hoon DSB. Zhang X, et al. Among authors: takeshima tl. Clin Transl Med. 2021 Oct;11(10):e608. doi: 10.1002/ctm2.608. Clin Transl Med. 2021. PMID: 34709752 Free PMC article.

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

Mori T, O'Day SJ, Umetani N, Martinez SR, Kitago M, Koyanagi K, Kuo C, Takeshima TL, Milford R, Wang HJ, Vu VD, Nguyen SL, Hoon DS. Mori T, et al. Among authors: takeshima tl. J Clin Oncol. 2005 Dec 20;23(36):9351-8. doi: 10.1200/JCO.2005.02.9876. J Clin Oncol. 2005. PMID: 16361635 Free PMC article. Clinical Trial.

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.

Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, Li MW, Huang SK, Sim MS, Morton DL, Hoon DS. Hoshimoto S, et al. Among authors: takeshima tl. J Invest Dermatol. 2012 Jun;132(6):1689-97. doi: 10.1038/jid.2012.36. Epub 2012 Mar 8. J Invest Dermatol. 2012. PMID: 22402438 Free PMC article.

Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival.

Zhang X, Bustos MA, Shoji Y, Ramos RI, Iida Y, Gentry R, Takeshima TL, Hoon DSB. Zhang X, et al. Among authors: takeshima tl. Cancers (Basel). 2021 Sep 18;13(18):4691. doi: 10.3390/cancers13184691. Cancers (Basel). 2021. PMID: 34572918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters